These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Alopecia areata. Gilhar A; Etzioni A; Paus R N Engl J Med; 2012 Apr; 366(16):1515-25. PubMed ID: 22512484 [No Abstract] [Full Text] [Related]
43. Clinical inquiries: childhood alopecia areata: what treatment works best? Haynes JW; Persons R; Jamieson B J Fam Pract; 2011 Jan; 60(1):45-52. PubMed ID: 21209981 [No Abstract] [Full Text] [Related]
44. Age dependence of diphenylcyclopropenone sensitization in patients with alopecia areata. Temesvári E; González R; Marschalkó M; Horváth A Contact Dermatitis; 2004 Jun; 50(6):381-2. PubMed ID: 15274737 [TBL] [Abstract][Full Text] [Related]
45. Topical and intralesional therapies for alopecia areata. Alkhalifah A Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245 [TBL] [Abstract][Full Text] [Related]
46. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation. Fiedler-Weiss VC; Buys CM Br J Dermatol; 1987 Dec; 117(6):759-63. PubMed ID: 3501310 [TBL] [Abstract][Full Text] [Related]
47. DPCP for the treatment of alopecia areata. Bolduc C; Shapiro J Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342 [TBL] [Abstract][Full Text] [Related]
49. Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone. Freyschmidt-Paul P; Hamm H; Happle R; Hoffmann R Eur J Dermatol; 1999 Mar; 9(2):111-4. PubMed ID: 10066958 [TBL] [Abstract][Full Text] [Related]
50. Two novel molecular mechanisms to account for the therapeutic efficacy of contact dermatitis against alopecia areata. Namazi MR Int Immunopharmacol; 2006 May; 6(5):862. PubMed ID: 16546718 [No Abstract] [Full Text] [Related]
51. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata. Tavakolpour S Scand J Immunol; 2016 May; 83(5):345-6. PubMed ID: 26939767 [No Abstract] [Full Text] [Related]
52. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata]. Valsecchi R; Pansera B; Rossi A; Cainelli T G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809 [TBL] [Abstract][Full Text] [Related]
53. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases. Malik K; Guttman-Yassky E J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S62-S64. PubMed ID: 29273110 [TBL] [Abstract][Full Text] [Related]